Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma of the Lungs”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02123849
What this trial is testing

Intermittent or Continuous Acetylsalicylic Acid and Gene Expression in the Nasal Tissue of Current Smokers

Who this might be right for
Lung CarcinomaTobacco Use Disorder
National Cancer Institute (NCI) 54
Testing effectiveness (Phase 2)Study completedNCT01553916
What this trial is testing

Neuroprotective Effects of Lithium in Patients With Small Cell Lung Cancer Undergoing Radiation Therapy to the Brain

Who this might be right for
Small Cell Lung Carcinoma
Washington University School of Medicine 19
Testing effectiveness (Phase 2)Ended earlyNCT03256721
What this trial is testing

Compare Apatinib Plus Chemotherapy Drug Versus Chemotherapy Drug as Second-line Treatment in NSCLC

Who this might be right for
Nonsmall Cell Lung Cancer
Fuzhou General Hospital 37
Testing effectiveness (Phase 2)Ended earlyNCT02109016
What this trial is testing

Assess the Efficacy and Safety of the VEGFR-FGFR Inhibitor, Lucitanib, Given to Patients With Advanced/Metastatic Lung Cancer and FGF, VEGF, or PDGF Related Genetic Alterations

Who this might be right for
Non-Small Cell Lung CancerSquamous Non-Small Cell Lung CancerNSCLC+6 more
Clovis Oncology, Inc. 18
Not applicableNot Yet RecruitingNCT07062484
What this trial is testing

A Real-world Study of the Efficacy and Safety of PD-1 Inhibitors Combined With Chemoradiotherapy in Lung Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Lung Metastatic Nasopharyngeal Carcinoma
Sichuan Cancer Hospital and Research Institute 600
Testing effectiveness (Phase 2)WithdrawnNCT02924233
What this trial is testing

Sym004 in Combination With Nivolumab Versus Nivolumab Monotherapy in EGFR-amplified Squamous Non-Small Cell Lung Cancer

Who this might be right for
Squamous Non-Small Cell Lung Cancer
Symphogen A/S
Early research (Phase 1)Looking for participantsNCT05877599
What this trial is testing

NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation

Who this might be right for
Non-small Cell Lung CancerHead and Neck Squamous Cell CarcinomaColorectal Carcinoma+5 more
AstraZeneca 45
Early research (Phase 1)Looking for participantsNCT06046495
What this trial is testing

The Oral EGFR Inhibitor PLB1004 in Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Avistone Biotechnology Co., Ltd. 81
Not applicableStudy completedNCT02440854
What this trial is testing

Evaluate the Impact of Afatinib on Quality of Life and Symptom Burden of Greek Subjects With Advanced NSCLC in Routine Patient Care Settings

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Boehringer Ingelheim 80
Early research (Phase 1)UnknownNCT02637531
What this trial is testing

A Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IPI-549

Who this might be right for
Advanced Solid Tumors (Part A/B/C/D)Non-small Cell Lung Cancer (Part E)Melanoma (Part E)+5 more
Infinity Pharmaceuticals, Inc. 219
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07463677
What this trial is testing

Tunlametinib Combination Therapy in KRAS-Mutated Unresectable Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer (NSCLC)
Sun Yat-sen University 55
Testing effectiveness (Phase 2)Study completedNCT01563354
What this trial is testing

3-arm Trial to Evaluate Pasireotide LAR/Everolimus Alone/in Combination in Patients With Lung/Thymus NET - LUNA Trial

Who this might be right for
Neuroendocrine Carcinoma of the Lung and Thymus
Novartis Pharmaceuticals 124
Not applicableWithdrawnNCT01325753
What this trial is testing

Cryotherapy in Treating Patients With Lung Cancer That Has Spread to the Other Lung or Parts of the Body

Who this might be right for
Advanced Malignant MesotheliomaExtensive Stage Small Cell Lung CancerLung Metastases+4 more
Wake Forest University Health Sciences
Large-scale testing (Phase 3)Study completedNCT00377156
What this trial is testing

Stereotactic Radiation Therapy With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases

Who this might be right for
Breast CancerCognitive/Functional EffectsLung Cancer+2 more
Alliance for Clinical Trials in Oncology 213
Early research (Phase 1)Study completedNCT00933777
What this trial is testing

SORAVE - Sorafenib and Everolimus in Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol SpecificNon-Small Cell Lung Cancer
University of Cologne 36
Not applicableTemporarily pausedNCT04638751
What this trial is testing

ARGONAUT: Stool and Blood Sample Bank for Cancer Patients

Who this might be right for
Non-small Cell Lung CancerColorectal CancerTriple Negative Breast Cancer+1 more
Persephone Biosciences 5,000
Large-scale testing (Phase 3)UnknownNCT05922345
What this trial is testing

Evaluation of the Efficacy and Safety of AL2846 Capsule Combined With TQB2450 Injection Compared to Docetaxel Injection in Advanced Non-small Cell Lung Cancer Patients Who Have Failed With Immunotherapy.

Who this might be right for
Non-small Cell Lung Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 518
Early research (Phase 1)Study completedNCT01958372
What this trial is testing

Radiation Therapy, Chemotherapy, and Soy Isoflavones in Treating Patients With Stage IIIA-IIIB Non-Small Cell Lung Cancer

Who this might be right for
Adenocarcinoma of the LungAdenosquamous Cell Lung CancerBronchoalveolar Cell Lung Cancer+5 more
Barbara Ann Karmanos Cancer Institute 11
Testing effectiveness (Phase 2)Study completedNCT01871805
What this trial is testing

Alectinib (CH5424802/RO5424802) in Participants With Anaplastic Lymphoma Kinase (ALK)-Rearranged Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-Small Cell Lung Cancer
Hoffmann-La Roche 134
Testing effectiveness (Phase 2)Study completedNCT00308529
What this trial is testing

Irinotecan, Carboplatin, Bevacizumab, and Radiation Therapy in the Treatment of Limited Stage Small Cell Lung Cancer

Who this might be right for
Carcinoma, Small Cell LungLung Cancer
SCRI Development Innovations, LLC 55
Next Page